AOM Infusion, a leading provider of specialty infusion therapy, announced today that it has been selected by GC Biopharma as a limited distribution partner for ALYGLO(TM), an FDA-approved ...

CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited ...

GC Biopharma enhances IVIG safety profile with advanced prothrombotic impurity detection technology: Yongin, South Korea Tuesday, April 7, 2026, 17:00 Hrs [IST] GC Biopharma, a gl ...

GC Green Cross's blood product 'Alyglo (intravenous immunoglobulin (IVIG-SN) 10% formulation)' has become a new drug recognized by the U.S. Food and Drug Administration (FDA). This is the eighth ...

-- In September 2024, GC Biopharma USA, Inc. announced the launch and distribution of its IG product ALYGLO (IVIG), the company's first 10% IVIG therapy for the treatment of adult patients aged 17 ...

KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA as a limited distribution partner to provide Alyglo (Immune Globulin Intravenous, Human-stwk) 10 per ...

TEANECK, N.J., July 16, 2025 /PRNewswire/ -- GC Biopharma USA, Inc., a leader in plasma-derived products, announced the presentation of new data on the viscosity of several commercially available 10% ...

Alyglo Global Market Report 2025 : Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Alyglo Global Market Report 2025 – Market Size, Trends, And Global Forecast ...